Job Description

Job Title: Manager / Sr Manager - Financial Planning & Analysis (FP&A) xe2x80x93 Polypeptide GroupLocation: Ambernath, IndiaJob Type: Full-TimeReporting: Head of FP&A and IRAbout Polypeptide Group:Polypeptide Group is a global leader in providing custom peptide-based solutions for the pharmaceutical, biotechnology, and life sciences industries. With a strong emphasis on quality and innovation, we specialize in the development and manufacturing of therapeutic peptides and are committed to advancing the future of peptide-based therapies. Our comprehensive service offerings, from discovery through commercial manufacturing, support the creation of life-changing drugs.Position Overview:We are seeking an experienced and detail-oriented FP&A (Senior) Manager to join our finance team at Polypeptide Group. This position reports to the Head of FP&A and Investor Relations (xe2x80x9cIRxe2x80x9d) and plays a crucial role in driving the financial strategy and decision-making processes within a fast-paced peptide CDMO environment. The ideal candidate will have experience in financial planning and analysis within a public company environment, specifically within the pharmaceutical, biotech, or CDMO sectors, and will be passionate about helping shape the financial future of our rapidly growing business.Key Responsibilities:

• Deliver monthly, bi-annual and annual financial reports, focusing on key performance indicators (KPIs), revenue trends, cost structures, and profitability across our global development and manufacturing sites. Provide insightful analyses on actual and forecasted profitability and proactively suggest measures to drive margin optimization.
• Prepare templates, consolidation tools, and help manage the annual budgeting process, including revenue, costs, and capital expenditures. Consolidate inputs from various functions into Group financials and develop numbers into a concise storyline for presentation to the Board of Directors.
• Develop and maintain state-of-the-art financial models to support forecasting and scenario planning across our global network.
• Drive continuous improvement in financial processes, systems (incl. ERP), and tools to ensure effective reporting, forecasting, and analysis.
• Prepare ad-hoc reports & analyses for senior management and key stakeholders to support strategic decisions.

Qualifications & Requirements:

• Masterxe2x80x99s degree in Finance, Accounting, Economics, Financial Analysis, Risk and investment Analysis, Business Analysis, Economic Policy and analysis etc. Certifications in FP & A are preferrable.
• MBA in Finance is an added advantage.
• 15+ years of experience in Controlling and/or FP&A, with a strong preference for candidates with a background in the pharmaceutical, biotechnology, or CDMO sectors.
• Currently in Manager role with similar profile at least 2 to 3 years.
• Strong understanding of peptide synthesis, drug development, and the regulatory environment for pharmaceutical manufacturing is a plus.
• Advanced proficiency in financial analysis tools, Excel, ERP systems (SAP, Microsoft Dynamics or similar), and business intelligence platforms.
• Excellent communication skills with the ability to present complex financial data to non-financial stakeholders, including senior leadership.
• Detail-oriented with a strong ability to analyze and interpret financial data in the context of operational performance.
• Self-motivated, proactive, and capable of managing multiple priorities in a fast-paced environment.

Why Join Us at Polypeptide Group:Polypeptide Group offers an exciting opportunity to work at the forefront of peptide-based therapeutics, a rapidly growing and innovative segment of the pharmaceutical industry. As a key member of our finance team, you will have the opportunity to contribute to a company that is dedicated to the success of its clients and the advancement of peptide science. Join us and be part of a global organization that is shaping the future of life-saving therapies.PolyPeptide Group AG and its consolidated subsidiaries (xe2x80x9cPolyPeptidexe2x80x9d) is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world.PolyPeptide offers products and services from pre-clinical through to commercial stages, including generics. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Dating back to 1952, PolyPeptide today runs a global network of six cGMP-certified facilities in Europe, the U.S. and India. PolyPeptide Group AGxe2x80x99s shares (SIX: PPGN) are listed on SIX Swiss Exchange.

PolyPeptide Group